Press Release Oncology Venture A/S Issues 1,619,912 Shares in Exchange for Previously Annulled Warrants

NEXT STORY
Press Release Oncology Venture calls third investment tranche under its share subscription agreement with Global Corporate Finance
PREV STORY
Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with KEYTRUDA®

author_avatar
NASDAQ Market News

TESARO and ENGOT Announce Presentation of Successful Niraparib Phase 3 ENGOT-OV16/NOVA Trial Results During ESMO 2016

Simultaneous presentation of data at ESMO and publication online in the New England Journal ...

author_avatar
NASDAQ Market News

Interventional Radiology Market Size to Reach $27.3 Billion by 2024, Gastroenterology Segment to Witness Significant Growth: P&S Intelligence

author_avatar
NASDAQ Market News